Close
Back to mobile site

More on VERU

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+87.5% Growth)
- Ratings (8.6 Score)

Upcoming Events

- Earnings (5/9/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Veru, Inc. (NQ:VERU)
Delayed: 1.41 +0.14 (11.02%)
Prev. Close $1.27  
Open$1.29 
52 Wk High$ 
52 Wk Low$ 
Day High$1.48 
Day Low$1.29 
P/E N/A  
EPS$ 
Volume1,111,920 

Friends, Peers and Foes (?): BWV (more...)

Apr 15, 2024 05:50 AM Veru, Inc. (VERU) PT Lowered to $5 at Oppenheimer
Apr 1, 2024 04:33 PM Form DEFA14A VERU INC.
Apr 1, 2024 04:05 PM Veru Announces Date of 2024 Annual Meeting of Shareholders
Apr 1, 2024 03:43 PM Form 10-Q VERU INC. For: Dec 31
Apr 1, 2024 03:31 PM Form 10-K/A VERU INC. For: Sep 30
Mar 27, 2024 04:23 PM Raymond James Starts Veru, Inc. (VERU) at Outperform
Mar 22, 2024 04:52 PM Form DEFA14A VERU INC.
Mar 22, 2024 04:05 PM Veru Reschedules Annual Meeting of Shareholders
Mar 12, 2024 08:00 AM Veru, Inc. (VERU) Appoints Louis Aronne as Chief Medical Advisor
Mar 12, 2024 08:00 AM Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
View All Articles

Entities mentioned with VERU

View All Entities